This site is intended for healthcare professionals

Can a person live without the pancreas?

Time : 8th of December 2022 01:18:42 PM Physician/Medicine,Oncology,General Surgery,Gastroenterology

A 58-year-old man with severe abdominal pain underwent surgery to remove the pancreas and spleen after diagnosis of intraductal papillary mucinous neoplasm or pancreatic cancer in 2016. He received chemotherapy for nine months to get rid of residual cancer. Although the patient is diabetic now, he is living a new life and coping by taking insulin and other pills to compensate.
  Cleveland Clinic

Cancer regression without treatment is very rare

Time : 8th of December 2022 09:40:03 AM Physician/Medicine,Oncology

A pooled analysis was conducted on more than 5,000 cancer patients with advanced solid tumours who were treated with a placebo in 45 randomized controlled trials. The findings revealed that only 1% of them achieved some response without actual treatment. However, complete regression of cancer in the absence of treatment was extremely rare and almost 0%.
  Twitter @oncology_bg

A blood test to diagnose 50 types of cancer

Time : 5th of December 2022 01:32:33 PM Oncology,Diagnostics & Pathology

The Galleri test is a game-changing diagnostic technique far more efficient than other tests. It tests circulating tumor or cell-free DNA in patients' blood samples using next-generation DNA sequencing techniques. The test detects cancer and where it likely started with 90% accuracy. A positive test should be followed by a CT scan or ultrasound to verify the results.
  Twitter @ClevelandClinic

Cancer patients may not benefit from cannabis oil

Time : 1st of December 2022 12:46:15 PM Psychiatry & Mental Health,Oncology

A trial analysed the effects of cannabidiol oil in relieving anxiety, depression, pain, and quality of life. It found no detectable effects of cannabis oil on emotional and physical functioning, quality of life, nausea, vomiting, fatigue, appetite, and dyspnoea. However, some experts believe CBD gives a feeling of general well-being even if it does not relieve symptoms.

Biotech firm voluntarily withdraws bladder cancer indication of its drug

Time : 30th of November 2022 10:31:06 AM Pharma News,Oncology

Tecentriq® (atezolizumab) had an indication for treating adults with urothelial carcinoma with PDL1 expression who are not eligible for cisplatin and platinum chemotherapies. The decision came after the drug failed to meet the primary endpoint in a trial and the requirements for FDA's Accelerated Approval Program. This withdrawal does not affect the drug's other indications.

Vegan diet could lower the chances of colorectal cancer in men

Time : 29th of November 2022 12:33:22 PM Oncology,Nutrition & Fitness,Gastroenterology

Consuming a diet rich in whole grains, vegetables, and beans can reduce the risk of colorectal cancer in men by almost 22%, according to a study. However, this benefit was not observed in women. Researchers believed that antioxidants in vegetables could be the reason for suppressing chronic inflammation, thereby reducing the chances of colorectal cancer.
  Today UK News

Lung cancer screening programs improve the survival of lung cancer patients

Time : 29th of November 2022 10:16:20 AM Pulmonology,Oncology,Diagnostics & Pathology

Screening people for lung cancer using low-dose CT improved the 20-year survival of lung cancer patients by almost 80%, as per a study. However, only 16% of patients with lung cancer had a diagnosis at an early stage. Also, less than 6% of people eligible for an early screening get it. These findings highlight the benefits of annual screening programs.
  Pharmacy Times

One million cancer diagnoses were missed during the COVID-19 pandemic

Time : 28th of November 2022 10:10:08 AM Oncology,Diagnostics & Pathology

European experts are warning about an imminent cancer epidemic unless steps are taken to curb it and boost treatment. They believe the impact of the pandemic could set back cancer treatment and outcomes by nearly a decade. The missed diagnosis can cause diagnoses at later stages, increasing the burden on the healthcare system and reducing patient survival and quality of life.
  The Guardian

Targeting non-cancerous cells in cancerous tumors can help fight against cancer

Time : 25th of November 2022 10:02:41 AM Pharma News,Oncology

Research on complex microenvironments of tumors revealed that cancer cells could instruct other cells to create nests for cancer cells to migrate and form secondary tumors. Interrupting these networks can stop cancer spread and improve the survival of cancer patients. Experts plan to develop drugs that can teach the immune system to stall the cells that help cancer cells.
  The Guardian

FDA urges for more restrictions on ovarian cancer drugs

Time : 24th of November 2022 11:35:33 AM Pharma News,Oncology,Obstetrics & Gynaecology

The agency has asked Clovis Oncology and GSK to restrict indications for their PARP inhibitors, rucaparib and niraparib, respectively, after recent data revealed a higher risk of death with this kind of drugs compared with chemotherapy. GSK already announced that it would limit the indications for patients with BRCA mutations while Clovis is currently evaluating FDA's request.
  Fierce Pharma